Cargando…
Synergistic Cytotoxic Effect from Combination of Wedelolactone and Cisplatin in HeLa Cell Line: A Novel Finding
CONTEXT AND OBJECTIVE: Cisplatin is a platinum drug in current clinical use for the treatment of cervical cancer. However, drug toxicity and resistance are its two major limitations. The aim of this investigation was to test the cytotoxic activity of potential phytochemicals alone and in combination...
Autores principales: | Sarwar, Sadia, Yu, Jun Qing, Nadeem, Humaira, Huq, Fazlul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519871/ https://www.ncbi.nlm.nih.gov/pubmed/33061291 http://dx.doi.org/10.2147/DDDT.S261321 |
Ejemplares similares
-
Enhanced Accumulation of Cisplatin in Ovarian Cancer Cells from Combination with Wedelolactone and Resulting Inhibition of Multiple Epigenetic Drivers
por: Sarwar, Sadia, et al.
Publicado: (2021) -
Synergistic Enhancement of Cisplatin Cytotoxicity by SN‐38, an Active Metabolite of CPT‐11, for Cisplatin‐resistant HeLa Cells
por: Minagawa, Yukihisa, et al.
Publicado: (1994) -
Synergistic effects of Ferula gummosa and radiotherapy on induction of cytotoxicity in HeLa cell line
por: Forouzmand, Seyed Hamid, et al.
Publicado: (2018) -
Effect of Ku80 on the radiosensitization of cisplatin in the cervical carcinoma cell line HeLa
por: Zhuang, Liang, et al.
Publicado: (2018) -
In vitro cytotoxic activity of menispermaceae plants against HeLa cell line
por: Thavamani, B. Samuel, et al.
Publicado: (2013)